Anthony Lembo
The Cleveland Clinic · Beth Israel Deaconess Medical Center · Beth Israel Deaconess Medical Center, Boston
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anthony Lembo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:09 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06257472 · Efficacy of Virtual Reality (VR) for Irritable Bowel SyndromeAnthony Lembo · withdrawn · IBS - Irritable Bowel Syndrome · principal investigator
- Early Ph1NCT04627727 · Effect of a Low FODMAP Diet on SIBO Breath Test PositivityBeth Israel Deaconess Medical Center · terminated · SIBO · principal investigator
- Ph4NCT04486326 · Crofelemer for Functional DiarrheaBeth Israel Deaconess Medical Center · terminated · Diarrhea · principal investigator
- Ph1NCT02847481 · A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBSBeth Israel Deaconess Medical Center · completed · Irritable Bowel Syndrome · principal investigator
- Ph3NCT00607971 · Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)Alizyme · terminated · Constipation-Predominant Irritable Bowel Syndrome · principal investigator
- Ph3NCT00268879 · Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)Alizyme · completed · Irritable Bowel Syndrome · principal investigator
- N/ANCT00179582 · Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBSBeth Israel Deaconess Medical Center · terminated · IBS · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Efficacy of Open-Label Placebo, Double-Blind Placebo, and Peppermint Oil in IBSR01AT008573 · NCCIH · BETH ISRAEL DEACONESS MEDICAL CENTER · fiscal years 2015 to 2019 · $174,009 awarded in 2019Same name and institution; not confirmed by an ID
- ACUPUNCTURE IN IBSM01RR001032 · NCRR · BETH ISRAEL DEACONESS MEDICAL CENTER · fiscal years 2005 to 2006 · $670,638 awarded in 2006Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:09 UTC. The ranking covers the 200 most relevant of 85 PubMed records, and a shared surname and initials can bring in a namesake. All 85 on PubMed
- Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome.BMJ · 2008858 citationsRCR 29.2
- Rifaximin therapy for patients with irritable bowel syndrome without constipation.N Engl J Med · 2011757 citationsRCR 24.5
- Placebos without deception: a randomized controlled trial in irritable bowel syndrome.PLoS One · 2010578 citationsRCR 20.1
- Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.Am J Gastroenterol · 2012377 citationsRCR 13.6
- A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation.Am J Gastroenterol · 2012317 citationsRCR 12.0
- Two randomized trials of linaclotide for chronic constipation.N Engl J Med · 2011291 citationsRCR 9.8
- Eluxadoline for Irritable Bowel Syndrome with Diarrhea.N Engl J Med · 2016254 citationsRCR 11.2
- Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.Gastroenterology · 2016227 citationsRCR 10.3
- Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation.Gastroenterology · 2010179 citationsRCR 6.1
- Efficacy of linaclotide for patients with chronic constipation.Gastroenterology · 2010169 citationsRCR 6.1